Short Interest in Venus Concept Inc. (NASDAQ:VERO) Decreases By 42.6%

Posted by Joseph Casey on Jan 16th, 2025

Venus Concept Inc. (NASDAQ:VERO – Get Free Report) was the target of a large drop in short interest in December. As of December 31st, there was short interest totalling 55,500 shares, a drop of 42.6% from the December 15th total of 96,700 shares. Approximately 1.3% of the shares of the stock are sold short. Based on an average daily trading volume, of 946,700 shares, the days-to-cover ratio is presently 0.1 days.

Hedge Funds Weigh In On Venus Concept

An institutional investor recently raised its position in Venus Concept stock. Masters Capital Management LLC lifted its stake in Venus Concept Inc. (NASDAQ:VERO – Free Report) by 100.0% in the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 666,702 shares of the company’s stock after purchasing an additional 333,366 shares during the quarter. Masters Capital Management LLC owned about 10.49% of Venus Concept worth $522,000 at the end of the most recent reporting period. 87.41% of the stock is currently owned by institutional investors and hedge funds.

Venus Concept Trading Down 3.5 %

NASDAQ VERO opened at $0.35 on Thursday. The business has a 50 day simple moving average of $0.35 and a two-hundred day simple moving average of $0.49. The company has a debt-to-equity ratio of 2.83, a quick ratio of 1.18 and a current ratio of 1.86. Venus Concept has a 1-year low of $0.28 and a 1-year high of $2.22.

Venus Concept Company Profile

(Get Free Report)

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.